Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 2Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 174Myeloid 64Lymphoid 28Thoracic 7Gastrointestinal 5Classical hematology 5Breast 4Plasma cell 3Genitourinary 3Sarcoma 2Head & Neck 2Gynecologic 2Dermatologic 1CNS 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 2Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cyclophosphamide 93Doxorubicin 92Radiotherapy 87Temozolomide 69Filgrastim 58Ifosfamide 55Bevacizumab 55Etoposide 48Gemcitabine 44Imatinib Mesylate 43Vincristine 40pembrolizumab 35pazopanib 34Peripheral Blood Stem Cell Transplantation 31Methotrexate 31Nivolumab 30Carboplatin 30fludarabine phosphate 29Irinotecan 29Cisplatin 28Paclitaxel 26Melphalan 26Magnetic Resonance Spectroscopy 26Docetaxel 25Busulfan 25Trabectedin 24apatinib 22Specimen Handling 21Sirolimus 21Antilymphocyte Serum 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Azacitidine × Sarcoma × Clear all
NCT06158399 2025-02-19

AZA Combined With RCHOP in P53-mutated DLBCL.

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting
52 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

NCT06778902 2025-01-16

Dragon

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 2 Not yet recruiting
80 enrolled
LymphoidSarcoma

Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡